MARCH BIOSCIENCES INC
Transforming Patient Care by Unlocking New Target Spaces
HOUSTON, United States · Founded 2024 · $32.4M raised
- Headquarters
- HOUSTON, Texas
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- march.bio
- Total Funding
- $32.4M
- Last Round
- $28.4M Series AOct 2024
- Rounds
- 2
About
March Biosciences is a Houston, Texas clinical-stage cell therapy company focused on developing CAR-T cell therapies for challenging hematological cancers. Its lead asset, MB-105, is a CD5-targeted CAR-T therapy in Phase 2 clinical trials for relapsed/refractory T-cell lymphoma and has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation. The company was launched from Baylor College of Medicine's Center for Cell and Gene Therapy and has raised over $53 million to date.
Summary
MARCH BIOSCIENCES INC is a Biotech company based in HOUSTON, United States, founded in 2024. It has raised $32.4M in total across 2 rounds, most recently a $28.4M Series A round in Oct 2024. Investors include Mission BioCapital, 4BIO Capital and Cancer Focus Fund.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...